Ad is loading...
FSMAX
Price
$95.84
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
LMNOX
Price
$43.28
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

FSMAX vs LMNOX

Header iconFSMAX vs LMNOX Comparison
Open Charts FSMAX vs LMNOXBanner chart's image
Fidelity Extended Market Index
Price$95.84
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Patient Opportunity I
Price$43.28
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FSMAX vs LMNOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMAX vs. LMNOX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and LMNOX is a StrongSell.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. LMNOX (1.61B). FSMAX pays higher dividends than LMNOX: FSMAX (1.10) vs LMNOX (0.00). FSMAX was incepted earlier than LMNOX: FSMAX (13 years) vs LMNOX (24 years). LMNOX is a more actively managed with annual turnover of: 40.00 vs. FSMAX (18.00). FSMAX has a lower initial minimum investment than LMNOX: FSMAX (0) vs LMNOX (1000000). LMNOX annual gain was more profitable for investors over the last year : 48.88 vs. FSMAX (38.09). FSMAX return over 5 years is better than : 56.62 vs. LMNOX (44.16).
FSMAXLMNOXFSMAX / LMNOX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years24 years-
Gain YTD22.77729.07878%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets40B1.61B2,484%
Annual Yield % from dividends1.100.00-
Returns for 1 year38.0948.8878%
Returns for 3 years7.70-4.76-162%
Returns for 5 years56.6244.16128%
Returns for 10 years85.67109.8378%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LFMD5.690.27
+4.98%
LifeMD
CULP5.090.13
+2.62%
Culp
SFM145.893.14
+2.20%
Sprouts Farmers Market
GILD89.761.13
+1.27%
Gilead Sciences
VCYT38.94-0.26
-0.66%
Veracyte